Slide show: Wheeling and dealing at J.P. Morgan 2012

Launch slide show >>

FierceBiotech's news team met with a number of drug developers this week at the J.P. Morgan Healthcare Conference in San Francisco, and wanted to put our readers up close to the action. So, in addition to our laptops, we toted cameras into our meetings with company chiefs (OK, most of us snapped photos with our smartphones). This slide show gives you a quick take on the status of each of the companies and pictures of the leaders as they looked on very little sleep and, in many cases, after too many meetings to count. Launch slide show >>

Suggested Articles

Antivirals from Roche, Bristol Myers Squibb, Viiv and Gilead, or modified versions of them, could prove effective against COVID-19, researchers said.

After posting positive data that showed it could help slow down the degenerative ALS disease, Amylyx has been given a $30 million boost.

Sumitomo is looking to the merged pipeline to help offset the anticipated impact of the arrival of generic competitors to bipolar drug Latuda.